Phylo phylo.bio launches with $13.5 million seed round from Andreeson. Their product: Biomni Lab, accelerates AI-native biology, allowing scientists — working across physical and computational fields — to plan, author, execute, and collaborate on complex research tasks with state-of-the-art agentic AI in a fully integrated workspace.
Drawn by high demand and Medicare reimbursement rules that reward expensive drugs and procedures, private equity firms have acquired hundreds of oncology practices nationwide, reshaping how cancer care is delivered and financed. This transformation is not merely structural—it has fundamentally altered the incentives that guide treatment decisions. https://bullmooseproject.org/posts/private-equity-in-cancer-care